Zevalin Post-marketing Surveillance in Japan

Clinical trial NCT01448928 · COMPLETED

Trial details

NCT number: NCT01448928
Sponsor: Spectrum Pharmaceuticals, Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Hodgkin's Lymphoma (NHL)

Start date: 2008-09-01
Primary completion: 2018-01-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.